I was part of the first Tysabri trial, and as it turned out, I was in the placebo group, which was a great relief at the time. The trial was stopped soon after it started because the PI at UCSF became aware of the PML that had occurred within first trial.
I personally would not go near Tysabri because of PML, even though it has a much higher efficacy than the other drugs. I'm on Copaxone, even knowing that its effectiveness is limited.
I'm personally interested in Functional Medicine approaches to MS, such as Dr. Terry Wahls spoke about in a recent TED Talk. See:
http://www.thewahlsfoundation.com/dr-wahls-gives-tedx-talk-on-overcoming-multiple-sclerosis/In addition, Dr. Ellen Mowry at UCSF recently published research (Annals of Neurology 2012) that shows that higher SAFE dosages of Vitamin D reduce the activity of MS in the brain. The study focused on variations in blood serum levels of Vitamin D at the lower safe range and did not study blood serum levels at a high safe range.
I believe that studying higher levels is the next step. Dr. Von Wee Yong from U of Calgary gave a presentation at UCSF in Oct. 2009 in which he said something very close to the following: "In the right dosages, Vitamin D is more potent against MS than any of the currently available drugs."
Dr. Yong's research involved serum levels of Vitamin D in the higher safe range, but it involved in vitro lab research and did not include the necessities of a Phase 1 safety trial or a control group.
There are no rich drug companies pushing and funding research in Vitamin D, so Dr. Yong's insights may never reach the market.
Vitamin D can be toxic, so raising your blood serum levels must be done in consultation with your doctor. Make sure that your doctor approves of the dosage you take, and that you receive regular blood tests to determine your actual serum levels of Vitamin D.
However, I do not understand why neurologists would risk PML when Vitamin D toxicity is rare, reversible, usually non-fatal, and preventable with regular blood tests.